Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220389
Status:
COMPLETED
Last Update Posted:
2008-10-16
First Post:
2005-09-14
Brief Title:
Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder a Double-Blind Phase Followed by an Open-Label Extension Phase
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
2007-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-14
First Submit QC Date:
September 14 2005
Study First Post Date:
2005-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-10-15
Last Update Post Date:
2008-10-16
Last Update Post Date Type:
ESTIMATED